Federation Des Caisses Desjardins Du Quebec Vaxxinity, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $17.5 Billion
- Q2 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 825 shares of VAXX stock, worth $8. This represents 0.0% of its overall portfolio holdings.
Number of Shares
825
Previous 825
-0.0%
Holding current value
$8
Previous $592,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VAXX
# of Institutions
9Shares Held
469KCall Options Held
0Put Options Held
0-
Spire Wealth Management162KShares$1,6170.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ154KShares$1,5380.0% of portfolio
-
Xtx Topco LTD London, X067.1KShares$6710.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ43.8KShares$4380.0% of portfolio
-
Clarius Group, LLC Seattle, WA20KShares$2000.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $1.12M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...